| |
| |
|
| Insider
Information: |
Koven Andrew I |
| Relationship: |
Director |
| City: |
Miami |
| State: |
FL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
2,772,265 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$118,253 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,772,265 |
|
|
| Total
Value |
$118,253 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
POZEN Inc |
POZN |
President, Chief Busin... |
2015-06-03 |
1,476,674 |
2015-06-03 |
0 |
Premium* |
|
|
Aralez Pharmaceuticals Inc. |
ARLZ |
President & Chief Busi... |
2018-06-04 |
1,183,419 |
2016-02-05 |
0 |
Premium* |
|
|
Kala Pharmaceuticals, Inc. |
KALA |
|
2023-06-22 |
12,172 |
2021-06-17 |
0 |
Premium* |
|
|
NeuroBo Pharmaceuticals Inc |
NRBO |
Director |
2023-07-27 |
100,000 |
2023-07-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NRBO |
NeuroBo Pharmaceuticals I... |
Director |
– • – |
2023-07-27 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
0 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
|
– • – |
2023-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
8,915 |
12,172 |
0 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
|
– • – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,197 |
3,257 |
0 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
|
– • – |
2021-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
53,000 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
President & Chief Business Off |
• – – |
2018-06-04 |
4 |
AS |
$0.37 |
$58,590 |
D/D |
(156,573) |
1,183,419 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
President & Chief Business Off |
• – – |
2018-05-14 |
4 |
AS |
$0.52 |
$7,261 |
D/D |
(13,964) |
1,339,992 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
President & Chief Business Off |
• – – |
2018-03-19 |
4 |
AS |
$1.70 |
$16,556 |
D/D |
(9,739) |
1,353,956 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
President & Chief Business Off |
• – – |
2017-06-05 |
4 |
S |
$1.28 |
$207,110 |
D/D |
(161,906) |
1,363,695 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
President & CBO |
• – – |
2017-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
109,190 |
1,525,601 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
President & Chief Business Off |
• – – |
2017-03-20 |
4 |
AS |
$2.41 |
$18,858 |
D/D |
(7,825) |
1,416,411 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
President & Chief Business Off |
• – – |
2017-03-15 |
4 |
B |
$2.55 |
$50,920 |
D/D |
20,000 |
1,424,236 |
2.74 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
President & Chief Business Off |
• – – |
2016-06-03 |
4 |
D |
$3.97 |
$818,098 |
D/D |
(206,070) |
1,404,236 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
President & Chief Business Off |
• – – |
2016-05-12 |
4 |
B |
$3.49 |
$249,471 |
D/D |
71,500 |
1,610,306 |
2.74 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
President & Chief Business Off |
• – – |
2016-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
62,132 |
1,538,806 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
President & Chief Business Off |
• – – |
2016-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,476,674 |
1,476,674 |
0 |
- |
|
| POZN |
POZEN Inc |
President, Chief Business Ofc. |
• – – |
2015-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,476,674 |
1,476,674 |
0 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
